...
首页> 外文期刊>Journal of Photochemistry and Photobiology, B. Biology: Official Journal of the European Society for Photobiology >In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy
【24h】

In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy

机译:纳米姜黄素包封的光电相纳米粒子组合聚合纳米囊泡的增强药物载体效率和心脏抗肥大治疗潜力的体内评价:一种新的策略

获取原文
获取原文并翻译 | 示例
           

摘要

Curcumin, a naturally derived polyphenolic compound has potent activities against cardiac disease like reducing hypertrophy, increasing antioxidant activity, maintaining hormone levels and blood pressure etc. Polymeric curcumin nanoparticles is a solemn concern nowadays in accordance to improve the beneficial properties of curcumin by diminishing its disadvantages like hydrophobic nature thereby results in maximum delivery of drug curcumin at the target. This study demonstrated the application of curcumin capped gold loaded poly (lactic-co-glycolic acid) nanoparticles (CAu-PLGA Nps) for the inhibition of cardiac hypertrophy by preserving myocardial functions of Wister rat model. Rat models were arbitrarily divided into five groups and observation period was 10 weeks; 1. Control 2. Enalopril (EP), an hypertropic agent induced group 3. EP and Curcumin (C) 4. EP and Curcumin capped gold (CAu) Nps and 5. EP and CAu-PLGA Nps injected group. CAu-PLGA Nps was first synthesized from double emulsion -solvent evaporation method and were characterized by its adoptable techniques such as FT-IR, XRD, SEM and TEM analysis. These analyses demonstrate the encapsulation of curcumin capped gold nanoparticles into PLGA there confirms the successful synthesis of CAu-PLGA Nps. Animals studies illustrates that the CAu-PLGA Nps has significantly produced cardiac anti-hypertrophy and drug delivery when compared to the other groups. CAu-PLGA Nps exhibit increased survival rate, improved cardiac functions like cardiac systolic and diastolic function, maintaining heart weight and left ventricle pressure at the controlled level. Beneficiary activities of CAu-PLGA Nps were associated with its cardiovascular functions like anti-inflammatory, antioxidant, controls cardiomycete growth, increased drug delivery, prevents accumulation of cholesterol and prevents myocardial infarction.
机译:姜黄素,一种天然衍生的多酚化合物具有抗心脏病的有效活性,如减少肥大,增加抗氧化活性,维持激素水平和血压等。聚合物姜黄素纳米颗粒是根据提高姜黄素的有益特性,通过减少其缺点来始终是庄严的关注与疏水性质一样,从而导致在靶标的最大递送药物姜黄素。本研究证明姜黄素封装的金负载聚(乳酸 - 共乙醇酸)纳米颗粒(Cau-PLGA NPS)通过保护Wister大鼠模型的心肌功能来抑制心肌肥厚。大鼠模型被任意分为五组,观察期为10周; 1.对照2. Enaloplil(EP),一种胃浸剂诱导组3. EP和姜黄素(c)4。EP和姜黄素盖金(CAU)NPS和5.EP和CAU-PLGA NPS注入组。首先由双乳液蒸发方法合成CAU-PLGA NPS,其特征在于其可采用的技术,如FT-IR,XRD,SEM和TEM分析。这些分析证明姜黄素封端的金纳米颗粒的包封在PLGA中,证实了Cau-PLGA NP的成功合成。动物研究表明,与其他组相比,Cau-PLGA NPS具有显着产生的心脏抗肥大和药物递送。 CAU-PLGA NPS表现出增加的存活率,改善心脏功能,如心脏收缩和舒张功能,保持心脏重量和受控水平的左心室压力。 CAU-PLGA NPS的受益者活动与其心血管功能如抗炎,抗氧化剂,对照心肌瘤生长,增加药物递送,可防止胆固醇积累并阻止心肌梗死。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号